메뉴 건너뛰기




Volumn 25, Issue 2, 2005, Pages 139-142

Pulmonary abscess due to leflunomide use in rheumatoid arthritis: A case report

Author keywords

Infection; Leflunomide; Pulmonary abscess; Rheumatoid arthritis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; COLESTYRAMINE; LEFLUNOMIDE; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SULTAMICILLIN;

EID: 16344382778     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0493-6     Document Type: Article
Times cited : (8)

References (26)
  • 2
    • 0031865023 scopus 로고    scopus 로고
    • Mechanism of action of leflunomide in rheumatoid arthritis
    • Fox RI (1998) Mechanism of action of leflunomide in rheumatoid arthritis. J Rheumatol 25 [Suppl 53]:20-26
    • (1998) J Rheumatol , vol.25 , Issue.53 SUPPL. , pp. 20-26
    • Fox, R.I.1
  • 3
    • 0028792355 scopus 로고
    • Safety and effectiveness of leflunomide in treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study
    • Mladenovic V, Domljan Z, Rozman B, Dodevic J, Popovic M, Dimitrijevic M, Zivkovic M, Campion G, (1995) Safety and effectiveness of leflunomide in treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study. Arthritis Rheum 38:1595-1603
    • (1995) Arthritis Rheum , vol.38 , pp. 1595-1603
    • Mladenovic, V.1    Domljan, Z.2    Rozman, B.3    Dodevic, J.4    Popovic, M.5    Dimitrijevic, M.6    Zivkovic, M.7    Campion, G.8
  • 4
    • 12644249109 scopus 로고    scopus 로고
    • In vitro and in vivo effects of leflunomide, brequiner, or cyclosporin on pyrimidine biosynthesis
    • Silva HT, Cao W, Shorthouse RA, Loffer M, Morris RE (1997) In vitro and in vivo effects of leflunomide, brequiner, or cyclosporin on pyrimidine biosynthesis. Transplant Proc 29:1292-1293
    • (1997) Transplant Proc , vol.29 , pp. 1292-1293
    • Silva, H.T.1    Cao, W.2    Shorthouse, R.A.3    Loffer, M.4    Morris, R.E.5
  • 5
    • 0030032806 scopus 로고    scopus 로고
    • The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase
    • Davis JP, Cain GA, Pitts WJ, Magolda RL, Copeland RA (1996) The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. Biochemistry 35:1270-1273
    • (1996) Biochemistry , vol.35 , pp. 1270-1273
    • Davis, J.P.1    Cain, G.A.2    Pitts, W.J.3    Magolda, R.L.4    Copeland, R.A.5
  • 6
    • 0345503095 scopus 로고
    • Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans
    • Fairbanks LD, Bofil M, Ruckerman K, Simmonds HA (1995) Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. J Biol Chem 49:253-279
    • (1995) J Biol Chem , vol.49 , pp. 253-279
    • Fairbanks, L.D.1    Bofil, M.2    Ruckerman, K.3    Simmonds, H.A.4
  • 7
    • 0018823799 scopus 로고
    • Pyrimidine nucleotide biosynthesis in animals genes, enzymes, and regulation of UMP biosynthesis
    • Jones ME (1980) Pyrimidine nucleotide biosynthesis in animals genes, enzymes, and regulation of UMP biosynthesis. Ann Rev Biochem 49:253-279
    • (1980) Ann Rev Biochem , vol.49 , pp. 253-279
    • Jones, M.E.1
  • 10
    • 0037378668 scopus 로고    scopus 로고
    • Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis
    • Cutolo M, Sulli A, Ghiorzo P, Pizzorni C, Craviotto C, Villaggio B (2003) Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. Ann Rheum Dis 62:297-302
    • (2003) Ann Rheum Dis , vol.62 , pp. 297-302
    • Cutolo, M.1    Sulli, A.2    Ghiorzo, P.3    Pizzorni, C.4    Craviotto, C.5    Villaggio, B.6
  • 11
    • 0029585361 scopus 로고
    • Importance of ribonucleotide availability to proliferating T lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibition
    • Fairbanks LD, Bofill M, Ruckemann K, Simmonds HA (1995) Importance of ribonucleotide availability to proliferating T lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibition. J Biol Chem 270:29682-29689
    • (1995) J Biol Chem , vol.270 , pp. 29682-29689
    • Fairbanks, L.D.1    Bofill, M.2    Ruckemann, K.3    Simmonds, H.A.4
  • 12
    • 0032773737 scopus 로고    scopus 로고
    • A771726, the active metabolite of leflunomide, directly inhibits activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner
    • Halminton LC, Vojnovic I, Warner TD (1999) A771726, the active metabolite of leflunomide, directly inhibits activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner. Br J Pharmacol 127:1589-1596
    • (1999) Br J Pharmacol , vol.127 , pp. 1589-1596
    • Halminton, L.C.1    Vojnovic, I.2    Warner, T.D.3
  • 13
    • 0028177579 scopus 로고
    • Effects of leflunomide on constitutive and inducible pathways of cellular eicosanoid generation
    • Weithmann KU, Jeske S, Schlotte V (1994) Effects of leflunomide on constitutive and inducible pathways of cellular eicosanoid generation. Agents Actions 4:164-170
    • (1994) Agents Actions , vol.4 , pp. 164-170
    • Weithmann, K.U.1    Jeske, S.2    Schlotte, V.3
  • 14
    • 0001149081 scopus 로고    scopus 로고
    • Interactions between T cell plasma membrane and monocytes
    • Miossec P, Van der berg WB, Frestein GS (eds) Birkhäuser, Basel
    • Burger D, Dayer JM (1998) Interactions between T cell plasma membrane and monocytes. In: Miossec P, Van der berg WB, Frestein GS (eds) T cell arthritis. Birkhäuser, Basel, pp 111-128
    • (1998) T Cell Arthritis , pp. 111-128
    • Burger, D.1    Dayer, J.M.2
  • 16
    • 0029847123 scopus 로고    scopus 로고
    • A novel mechanism of action of the immunomodulatory drug, leflunomide: Augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2
    • Cao WW, Kao PN, Aoki Y, Xu JC, Shorthouse RA, Morris RE (1996) A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2. Transplant Proc 28:3079-3080
    • (1996) Transplant Proc , vol.28 , pp. 3079-3080
    • Cao, W.W.1    Kao, P.N.2    Aoki, Y.3    Xu, J.C.4    Shorthouse, R.A.5    Morris, R.E.6
  • 19
    • 0033053835 scopus 로고    scopus 로고
    • Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial
    • European Leflunomide Study Group
    • Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet 353:259-263
    • (1999) Lancet , vol.353 , pp. 259-263
    • Smolen, J.S.1    Kalden, J.R.2    Scott, D.L.3    Rozman, B.4    Kvien, T.K.5    Larsen, A.6    Loew-Friedrich, I.7    Oed, C.8    Rosenburg, R.9
  • 20
  • 21
    • 6744262231 scopus 로고    scopus 로고
    • A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
    • Oxford
    • Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP(2000) A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) 39:655-665
    • (2000) Rheumatology , vol.39 , pp. 655-665
    • Emery, P.1    Breedveld, F.C.2    Lemmel, E.M.3    Kaltwasser, J.P.4
  • 22
    • 0033509841 scopus 로고    scopus 로고
    • Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis
    • Weinblatt M, Kremer JM, Coblyn JS (1999) Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 42:1322-1328
    • (1999) Arthritis Rheum , vol.42 , pp. 1322-1328
    • Weinblatt, M.1    Kremer, J.M.2    Coblyn, J.S.3
  • 23
    • 0036049636 scopus 로고    scopus 로고
    • Peripheral neuropathy: An unwanted effect of leflunomide?
    • Carully MT, Davies UM (2002) Peripheral neuropathy: an unwanted effect of leflunomide? Rheumatology 41:952-953
    • (2002) Rheumatology , vol.41 , pp. 952-953
    • Carully, M.T.1    Davies, U.M.2
  • 24
    • 0037350340 scopus 로고    scopus 로고
    • Leflunomide induced vasculitis - A dose-response relationship
    • Chan ATY, Bradlow A, McNally J (2003) Leflunomide induced vasculitis - a dose-response relationship. Rheumatology 42:492-493
    • (2003) Rheumatology , vol.42 , pp. 492-493
    • Chan, A.T.Y.1    Bradlow, A.2    McNally, J.3
  • 25
    • 0344195566 scopus 로고    scopus 로고
    • Leflunomide for active arthritis
    • Bruyn GAW, Griep EN, Korff KJ (1999) Leflunomide for active arthritis. Lancet 353:883-884
    • (1999) Lancet , vol.353 , pp. 883-884
    • Bruyn, G.A.W.1    Griep, E.N.2    Korff, K.J.3
  • 26
    • 1542636277 scopus 로고    scopus 로고
    • Anaerobic infections of the lung
    • Chung G, Goetz MB (2000) Anaerobic infections of the lung. Curr Infect Dis Rep 2:238-244
    • (2000) Curr Infect Dis Rep , vol.2 , pp. 238-244
    • Chung, G.1    Goetz, M.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.